US Stock MarketDetailed Quotes

Cytek Biosciences (CTKB)

Watchlist
  • 5.400
  • -0.220-3.91%
Close Jan 16 16:00 ET
  • 5.400
  • 0.0000.00%
Post 16:10 ET
690.47MMarket Cap-49.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytek Biosciences (CTKB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
1.54%52.29M
-2.18%45.6M
-7.59%41.46M
3.85%200.45M
-1.30%57.48M
7.29%51.5M
-6.19%46.62M
20.96%44.86M
17.67%193.02M
20.48%58.23M
Operating revenue
1.54%52.29M
-2.18%45.6M
-7.59%41.46M
3.85%200.45M
-1.30%57.48M
7.29%51.5M
-6.19%46.62M
20.96%44.86M
17.67%193.02M
20.48%58.23M
Cost of revenue
9.99%24.74M
2.62%21.74M
-2.50%21.3M
6.89%89.35M
-5.40%23.82M
8.03%22.5M
-1.63%21.18M
36.12%21.85M
32.55%83.59M
32.82%25.19M
Gross profit
-5.01%27.55M
-6.17%23.87M
-12.41%20.16M
1.54%111.11M
1.83%33.65M
6.72%29.01M
-9.68%25.44M
9.39%23.01M
8.37%109.43M
12.51%33.05M
Operating expense
10.50%36.74M
1.55%34.49M
4.10%35.13M
-4.11%131.63M
-7.59%30.67M
-1.03%33.25M
-8.92%33.96M
1.65%33.75M
33.56%137.27M
13.30%33.19M
Selling and administrative expenses
18.90%27.79M
7.11%25.67M
6.08%25.41M
-0.96%92.23M
-6.15%20.94M
4.21%23.37M
-4.74%23.96M
3.12%23.95M
37.10%93.12M
14.19%22.32M
-Selling and marketing expense
-6.14%11.67M
-1.09%12.13M
-0.27%12.51M
-0.07%49.11M
2.71%11.87M
2.92%12.43M
-14.61%12.27M
12.54%12.54M
47.90%49.15M
28.04%11.56M
-General and administrative expense
47.33%16.12M
15.71%13.53M
13.06%12.9M
-1.95%43.11M
-15.68%9.07M
5.71%10.94M
8.42%11.69M
-5.57%11.41M
26.76%43.97M
2.29%10.76M
Research and development costs
-9.37%8.96M
-11.75%8.83M
-0.72%9.73M
-10.76%39.4M
-10.54%9.72M
-11.54%9.88M
-17.59%10M
-1.78%9.8M
26.66%44.15M
11.51%10.87M
Operating profit
-116.38%-9.19M
-24.59%-10.62M
-39.51%-14.98M
26.30%-20.52M
2,279.56%2.99M
33.83%-4.25M
6.57%-8.53M
11.74%-10.73M
-1,443.51%-27.85M
-263.10%-137K
Net non-operating interest income expense
-93.99%79K
-89.00%141K
-76.36%217K
138.60%10.36M
549.53%6.85M
27.95%1.31M
61.87%1.28M
-37.55%918K
112.22%4.34M
-45.64%1.05M
Non-operating interest income
-60.01%573K
-60.81%555K
-62.62%508K
61.55%10.36M
324.86%6.15M
-11.65%1.43M
17.90%1.42M
-36.58%1.36M
38.84%6.41M
-44.86%1.45M
Non-operating interest expense
315.13%494K
208.96%414K
-34.01%291K
----
----
-80.00%119K
-67.24%134K
-34.47%441K
-19.51%2.07M
-42.65%394K
Other net income (expense)
-56.52%1.34M
6,184.75%3.71M
324.30%3.49M
-42.74%4.46M
-84.63%491K
155.88%3.09M
-96.61%59K
-50.18%823K
665.62%7.79M
52.75%3.19M
Other non- operating income (expenses)
-56.52%1.34M
6,184.75%3.71M
324.30%3.49M
-42.74%4.46M
-84.63%491K
155.88%3.09M
-96.61%59K
-50.18%823K
665.62%7.79M
52.75%3.19M
Income before tax
-5,048.41%-7.77M
5.72%-6.78M
-25.28%-11.27M
63.72%-5.7M
151.11%10.32M
103.75%157K
-8.96%-7.19M
0.52%-8.99M
-1,346.75%-15.71M
-0.07%4.11M
Income tax
-192.22%-2.29M
-136.70%-1.19M
104.82%136K
108.99%320K
148.85%680K
-134.52%-784K
247.17%3.25M
-26.47%-2.82M
-190.93%-3.56M
-451.52%-1.39M
Net income
-682.15%-5.48M
46.49%-5.58M
-84.83%-11.4M
50.44%-6.02M
75.23%9.64M
114.58%941K
-137.78%-10.43M
9.37%-6.17M
-589.05%-12.15M
48.01%5.5M
Net income continuous Operations
-682.15%-5.48M
46.49%-5.58M
-84.83%-11.4M
50.44%-6.02M
75.23%9.64M
114.58%941K
-137.78%-10.43M
9.37%-6.17M
-589.05%-12.15M
48.01%5.5M
Minority interest income
0
0
Net income attributable to the parent company
-682.15%-5.48M
46.49%-5.58M
-84.83%-11.4M
50.44%-6.02M
75.23%9.64M
114.58%941K
-137.78%-10.43M
9.37%-6.17M
-571.58%-12.15M
55.94%5.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-682.15%-5.48M
46.49%-5.58M
-84.83%-11.4M
50.44%-6.02M
75.23%9.64M
114.58%941K
-137.78%-10.43M
9.37%-6.17M
-571.58%-12.15M
55.94%5.5M
Basic earnings per share
-500.00%-0.04
50.00%-0.04
-80.00%-0.09
44.44%-0.05
75.00%0.07
120.00%0.01
-166.67%-0.08
0.00%-0.05
-550.00%-0.09
33.33%0.04
Diluted earnings per share
-500.00%-0.04
50.00%-0.04
-80.00%-0.09
44.44%-0.05
75.00%0.07
120.00%0.01
-166.67%-0.08
0.00%-0.05
-550.00%-0.09
33.33%0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 1.54%52.29M-2.18%45.6M-7.59%41.46M3.85%200.45M-1.30%57.48M7.29%51.5M-6.19%46.62M20.96%44.86M17.67%193.02M20.48%58.23M
Operating revenue 1.54%52.29M-2.18%45.6M-7.59%41.46M3.85%200.45M-1.30%57.48M7.29%51.5M-6.19%46.62M20.96%44.86M17.67%193.02M20.48%58.23M
Cost of revenue 9.99%24.74M2.62%21.74M-2.50%21.3M6.89%89.35M-5.40%23.82M8.03%22.5M-1.63%21.18M36.12%21.85M32.55%83.59M32.82%25.19M
Gross profit -5.01%27.55M-6.17%23.87M-12.41%20.16M1.54%111.11M1.83%33.65M6.72%29.01M-9.68%25.44M9.39%23.01M8.37%109.43M12.51%33.05M
Operating expense 10.50%36.74M1.55%34.49M4.10%35.13M-4.11%131.63M-7.59%30.67M-1.03%33.25M-8.92%33.96M1.65%33.75M33.56%137.27M13.30%33.19M
Selling and administrative expenses 18.90%27.79M7.11%25.67M6.08%25.41M-0.96%92.23M-6.15%20.94M4.21%23.37M-4.74%23.96M3.12%23.95M37.10%93.12M14.19%22.32M
-Selling and marketing expense -6.14%11.67M-1.09%12.13M-0.27%12.51M-0.07%49.11M2.71%11.87M2.92%12.43M-14.61%12.27M12.54%12.54M47.90%49.15M28.04%11.56M
-General and administrative expense 47.33%16.12M15.71%13.53M13.06%12.9M-1.95%43.11M-15.68%9.07M5.71%10.94M8.42%11.69M-5.57%11.41M26.76%43.97M2.29%10.76M
Research and development costs -9.37%8.96M-11.75%8.83M-0.72%9.73M-10.76%39.4M-10.54%9.72M-11.54%9.88M-17.59%10M-1.78%9.8M26.66%44.15M11.51%10.87M
Operating profit -116.38%-9.19M-24.59%-10.62M-39.51%-14.98M26.30%-20.52M2,279.56%2.99M33.83%-4.25M6.57%-8.53M11.74%-10.73M-1,443.51%-27.85M-263.10%-137K
Net non-operating interest income expense -93.99%79K-89.00%141K-76.36%217K138.60%10.36M549.53%6.85M27.95%1.31M61.87%1.28M-37.55%918K112.22%4.34M-45.64%1.05M
Non-operating interest income -60.01%573K-60.81%555K-62.62%508K61.55%10.36M324.86%6.15M-11.65%1.43M17.90%1.42M-36.58%1.36M38.84%6.41M-44.86%1.45M
Non-operating interest expense 315.13%494K208.96%414K-34.01%291K---------80.00%119K-67.24%134K-34.47%441K-19.51%2.07M-42.65%394K
Other net income (expense) -56.52%1.34M6,184.75%3.71M324.30%3.49M-42.74%4.46M-84.63%491K155.88%3.09M-96.61%59K-50.18%823K665.62%7.79M52.75%3.19M
Other non- operating income (expenses) -56.52%1.34M6,184.75%3.71M324.30%3.49M-42.74%4.46M-84.63%491K155.88%3.09M-96.61%59K-50.18%823K665.62%7.79M52.75%3.19M
Income before tax -5,048.41%-7.77M5.72%-6.78M-25.28%-11.27M63.72%-5.7M151.11%10.32M103.75%157K-8.96%-7.19M0.52%-8.99M-1,346.75%-15.71M-0.07%4.11M
Income tax -192.22%-2.29M-136.70%-1.19M104.82%136K108.99%320K148.85%680K-134.52%-784K247.17%3.25M-26.47%-2.82M-190.93%-3.56M-451.52%-1.39M
Net income -682.15%-5.48M46.49%-5.58M-84.83%-11.4M50.44%-6.02M75.23%9.64M114.58%941K-137.78%-10.43M9.37%-6.17M-589.05%-12.15M48.01%5.5M
Net income continuous Operations -682.15%-5.48M46.49%-5.58M-84.83%-11.4M50.44%-6.02M75.23%9.64M114.58%941K-137.78%-10.43M9.37%-6.17M-589.05%-12.15M48.01%5.5M
Minority interest income 00
Net income attributable to the parent company -682.15%-5.48M46.49%-5.58M-84.83%-11.4M50.44%-6.02M75.23%9.64M114.58%941K-137.78%-10.43M9.37%-6.17M-571.58%-12.15M55.94%5.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -682.15%-5.48M46.49%-5.58M-84.83%-11.4M50.44%-6.02M75.23%9.64M114.58%941K-137.78%-10.43M9.37%-6.17M-571.58%-12.15M55.94%5.5M
Basic earnings per share -500.00%-0.0450.00%-0.04-80.00%-0.0944.44%-0.0575.00%0.07120.00%0.01-166.67%-0.080.00%-0.05-550.00%-0.0933.33%0.04
Diluted earnings per share -500.00%-0.0450.00%-0.04-80.00%-0.0944.44%-0.0575.00%0.07120.00%0.01-166.67%-0.080.00%-0.05-550.00%-0.0933.33%0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.41%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -